|
Pharmaceutical Technology's annual manufacturing investment update shows slight gains in biopharmaceutical manufacturing and emerging markets and continued restructuring of supply networks.
Aug 2, 2012
By:
Patricia Van Arnum
Pharmaceutical Technology's annual manufacturing investment update shows slight gains in biopharmaceutical manufacturing and emerging markets and continued restructuring of supply networks.
|
Approaches centre on ways to optimise process conditions and operability.
Aug 1, 2012
By:
Patricia Van Arnum
Approaches centre on ways to optimise process conditions and operability.
|
US spending on prescription drugs will increase through 2016 but at historically low levels as emerging markets are projected for double-digit growth.
Aug 1, 2012
By:
Patricia Van Arnum
US spending on prescription drugs will increase through 2016 but at historically low levels as emerging markets are projected for double-digit growth.
|
A podcast with Robert Farra, president and COO of MicroCHIPS, who discusses wirelessly controlled and programmable microchip-based drug delivery as an alternative to subcutaneous injections.
Aug 1, 2012
By:
Patricia Van Arnum
Al podcast with Robert Farra, president and COO of MicroCHIPS, who discusses wirelessly controlled and programmable microchip-based drug delivery as an alternative to subcutaneous injections.
|
|
An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars. This article is part of a special issue on outsourcing.
Aug 1, 2012
By:
Patricia Van Arnum
An examination of the current and projected market for biosimilars, development costs for biosimilars compared with small-molecule generic drug, and partnerships in biosimilars.
|
|
The manufacturing capacity-sharing model in biologics and Merck & Co. and MedImmune ushers in a new paradigm of "co-opetition". This article is part of a special issue on outsourcing.
Aug 1, 2012
By:
Patricia Van Arnum
The manufacturing capacity-sharing model in biologics and Merck & Co. and MedImmune ushers in a new paradigm of "co-opetition".
|
Abbott forms a partnership with the US Secretary of State's International Fund for Women and Girls to support grassroots organizations that are working to advance health, education, and economic opportunity for women in Burma.
Aug 1, 2012
By:
Patricia Van Arnum
Abbott forms a partnership with the US Secretary of State's International Fund for Women and Girls to support grassroots organizations that are working to advance health, education, and economic opportunity for women in Burma.
|
|
AMRI, a contract research and manufacturing organization, discusses its adaption of an insourcing model with Eli Lilly. This article is part of a special issue on outsourcing.
Aug 1, 2012
By:
Patricia Van Arnum
AMRI, a contract research and manufacturing organization, discusses its adaption of an insourcing model with Eli Lilly.
|
Nanolipogels for anticancer drug delivery, inhalable and thermo-responsive, fat-encased nanoparticles for targeted drug delivery, and calcium carbonate microspheres are some recent developments
Aug 1, 2012
By:
Patricia Van Arnum
Nanolipogels for anticancer drug delivery, inhalable and thermo-responsive, fat-encased nanoparticles for targeted drug delivery, and calcium carbonate microspheres are some recent developments.
|
|
